Oncogenically active MYD88 mutations in human lymphomaVu N. Ngo, Louis M. Staudt, Arthur L. Shaffer et al.|Nature|2010Cited by 1.5k
Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expressionKian‐Huat Lim, Isabel Aznarez|Nature Communications|2020Cited by 192
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNAAhmed O. Kaseb, Razelle Kurzrock, Nora Sánchez et al.|Clinical Cancer Research|2019Cited by 76
Abstract A081: Resistance Mechanisms to Monotherapy RAS(ON) Multi-Selective Inhibitor Daraxonrasib (RMC-6236) in RAS Mutant PDAC Inform Therapeutic Combination StrategiesIda Aronchik, Mallika Singh, Sumit Kar et al.|Molecular Cancer Therapeutics|2025Cited by 1